Titre :
  • Exquisite antitumour response to trastuzumab in a patient with no evidence of Ras-Raf-MAPK and PI3K-Akt pathways activation.
Auteur : Mano, Max S. ; Awada, Ahmad ; Minisini, A ; Durbecq, Virginie ; Di Leo, Angelo ; Piccart-Gebhart, Martine
Informations sur la publication : Breast, 13, 4, (page 347-349)
Statut de publication : Publié, 2004-08
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : Breast cancer
Epithelial growth factor
Raf kinase inhibitors
Survival pathways
Trastuzumab
Mots-clés MeSH : 1-Phosphatidylinositol 3-Kinase
Antibodies, Monoclonal -- therapeutic use
Antineoplastic Agents -- therapeutic use
Breast Neoplasms -- drug therapy
Breast Neoplasms -- genetics
Breast Neoplasms -- immunology
Drug Resistance, Neoplasm
Female
Genes, ras
Humans
Middle Aged
Mitogen-Activated Protein Kinase Kinases
Receptor, erbB-2 -- genetics
Treatment Outcome
raf Kinases
Note : Case Reports
Journal Article
Langue :
  • Anglais
Identificateurs : urn:issn:0960-9776 
info:doi/10.1016/j.breast.2003.11.009
info:pii/S0960977604000153
info:pmid/15325672